People · Operator
Named in public records as an officer, director or promoter · active 2016–2021 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Accolade, Inc. | — | Other Health Care | Series D+ | $661.1M | $200.1M | 2021 |
| Moderna Therapeutics, Inc. | — | Biotechnology | Growth/Late | $451.4M | $19.2B | 2016 |
Elizabeth Nabel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elizabeth Nabel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Noubar Afeyan | 1 | 9 |
| Lee Babiss | 1 | 5 |
| Lorence Kim | 1 | 5 |
| Peter Klein | 1 | 5 |
| PETER HUTT | 1 | 4 |
| John Mendlein | 1 | 4 |
| Stephane Bancel | 1 | 4 |
| Henri Termeer | 1 | 3 |
| J Michael Cline | 1 | 3 |
| James C. Madden, V | 1 | 3 |
| Patricia J. Wadors | 1 | 2 |
| Thomas K Spann | 1 | 2 |
| Thomas J Neff | 1 | 2 |
| Dawn J. Lepore | 1 | 2 |
| Arthur H. Spiegel | 1 | 2 |
| Stephen Hoge | 1 | 2 |
| James C Madden | 1 | 2 |
| John W Rowe | 1 | 1 |
| Edgar, Jr. T Bronfman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.